CHRAC1 Antikörper (Middle Region)
Kurzübersicht für CHRAC1 Antikörper (Middle Region) (ABIN927783)
Target
Alle CHRAC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Fruchtfliege (Drosophila melanogaster), Rind (Kuh), Hund
-
Aufreinigung
- Purified
-
Immunogen
- CHRAC1 antibody was raised in rabbit using the middle region of CHRAC1 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CHRAC1 Blocking Peptide, (ABIN5612857), is also available for use as a blocking control in assays to test for specificity of this CHRAC1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CHRAC1 (Chromatin Accessibility Complex 1 (CHRAC1))
-
Andere Bezeichnung
- CHRAC1
-
Hintergrund
- CHRAC1 is a histone-fold protein that interacts with other histone-fold proteins to bind DNA in a sequence-independent manner. These histone-fold protein dimers combine within larger enzymatic complexes for DNA transcription, replication, and packaging.CHRAC1 is a histone-fold protein that interacts with other histone-fold proteins to bind DNA in a sequence-independent manner. These histone-fold protein dimers combine within larger enzymatic complexes for DNA transcription, replication, and packaging. Synonyms: Polyclonal CHRAC1 antibody, Anti-CHRAC1 antibody, chromatin accessibility complex 1 antibody, CHARC1 antibody, CHARC15 antibody, CHRAC15 antibody, YCL1 antibody.
Target
-